{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:40:42Z","timestamp":1787316042405,"version":"build-2736575974"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007277","name":"Icahn School of Medicine at Mount Sinai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007277","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.lungcan.2020.12.025","type":"journal-article","created":{"date-parts":[[2020,12,30]],"date-time":"2020-12-30T20:25:21Z","timestamp":1609359921000},"page":"157-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Where are we with proton beam therapy for thoracic malignancies? Current status and future perspectives"],"prefix":"10.1016","volume":"152","author":[{"given":"Stanislav","family":"Lazarev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Rosenzweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Samstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas Resende","family":"Salgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaakir","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Press","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonam","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred R.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Charles B.","family":"Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.lungcan.2020.12.025_bib0005","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1120\/jacmp.v16i6.5678","article-title":"Beam-specific planning target volumes incorporating 4D CT for pencil beam scanning proton therapy of thoracic tumors","volume":"16","author":"Lin","year":"2015","journal-title":"J. Appl. Clin. Med. Phys."},{"issue":"1","key":"10.1016\/j.lungcan.2020.12.025_bib0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radonc.2017.08.005","article-title":"Systematic assessment of clinical outcomes and toxicities of proton radiotherapy for reirradiation","volume":"125","author":"Verma","year":"2017","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.lungcan.2020.12.025_bib0015","series-title":"Cancer Facts & Figures","author":"American Cancer Society","year":"2019"},{"issue":"4","key":"10.1016\/j.lungcan.2020.12.025_bib0020","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.semradonc.2017.04.009","article-title":"Thoracic radiation normal tissue injury","volume":"27","author":"Simone","year":"2017","journal-title":"Semin. Radiat. Oncol."},{"key":"10.1016\/j.lungcan.2020.12.025_bib0025","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.ijrobp.2010.03.012","article-title":"Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer","volume":"80","author":"Register","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"July 1","key":"10.1016\/j.lungcan.2020.12.025_bib0030","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.radonc.2018.02.024","article-title":"Photons, protons or carbon ions for stage I non-small cell lung cancer - Results of the multicentric ROCOCO in silico study","volume":"128","author":"Wink","year":"2018","journal-title":"Radiother. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2020.12.025_bib0035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0360-3016(02)04416-4","article-title":"Clinical evaluation of proton radiotherapy for non-small-cell lung cancer","volume":"56","author":"Shioyama","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.lungcan.2020.12.025_bib0040","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijrobp.2005.10.031","article-title":"High-dose proton beam therapy for Stage I non-small-cell lung cancer","volume":"65","author":"Nihei","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"July 3","key":"10.1016\/j.lungcan.2020.12.025_bib0045","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.ijrobp.2006.12.063","article-title":"Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I\/II clinical study","volume":"68","author":"Hata","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.lungcan.2020.12.025_bib0050","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.24998","article-title":"High-dose proton therapy and carbon-ion therapy for stage I nonsmall cell lung cancer","volume":"116","author":"Iwata","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2020.12.025_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2009.07.1707","article-title":"Proton beam therapy for patients with medically inoperable stage I non-small-cell lung cancer at the university of Tsukuba","volume":"78","author":"Nakayama","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.lungcan.2020.12.025_bib0060","doi-asserted-by":"crossref","DOI":"10.1097\/JTO.0b013e31824de0bf","article-title":"Proton SBRT for medically inoperable stage I NSCLC","volume":"7","author":"Westover","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2020.12.025_bib0065","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.ijrobp.2013.05.002","article-title":"High-dose hypofractionated proton beam radiation therapy is safe and effective for central and peripheral early-stage non-small cell lung cancer: results of a 12-year experience at Loma Linda University Medical Center","volume":"86","author":"Bush","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.lungcan.2020.12.025_bib0070","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3109\/0284186X.2014.948060","article-title":"High-dose proton beam therapy for stage I non-small cell lung cancer: clinical outcomes and prognostic factors","volume":"54","author":"Makita","year":"2015","journal-title":"Acta Oncol."},{"key":"10.1016\/j.lungcan.2020.12.025_bib0075","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1515\/raon-2017-0023","article-title":"High dose hypofractionated proton beam therapy is a safe and feasible treatment for central lung Cancer","volume":"51","author":"Ono","year":"2017","journal-title":"Radiol. Oncol."},{"key":"10.1016\/j.lungcan.2020.12.025_bib0080","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/1754-9485.12901","article-title":"Hypofractionated proton beam therapy for centrally located lung cancer","volume":"63","author":"Nakamura","year":"2019","journal-title":"J. Med. Imaging Radiat. Oncol."},{"key":"10.1016\/j.lungcan.2020.12.025_bib0085","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ijrobp.2018.02.022","article-title":"Phase 2 study of stereotactic body radiation therapy and stereotactic body proton therapy for high-risk, medically inoperable, early-stage non-small cell lung Cancer","volume":"101","author":"Nantavithya","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.lungcan.2020.12.025_bib0090","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.radonc.2017.05.007","article-title":"Comparison of particle beam therapy and stereotactic body radiotherapy for early stage non-small cell lung cancer: a systematic review and hypothesis-generating meta-analysis","volume":"123","author":"Chi","year":"2017","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.lungcan.2020.12.025_bib0095","article-title":"Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer","author":"Bradley","year":"2019","journal-title":"J Clin Oncol:JCO1901162"},{"key":"10.1016\/j.lungcan.2020.12.025_bib0100","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1200\/JCO.2016.71.6142","article-title":"Cardiac events after radiation therapy: combined analysis of prospective multicenter trials for locally advanced non-small-Cell lung Cancer","volume":"35","author":"Dess","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2020.12.025_bib0105","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13014-016-0640-8","article-title":"Establishing the feasibility of the dosimetric compliance criteria of RTOG 1308: phase III randomized trial comparing overall survival after photon versus proton radiochemotherapy for inoperable stage II-IIIB NSCLC","volume":"11","author":"Giaddui","year":"2016","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.lungcan.2020.12.025_bib0110","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1200\/JCO.2017.74.0720","article-title":"Bayesian adaptive randomization trial of passive scattering proton therapy and intensity-modulated photon radiotherapy for locally advanced non-small-Cell lung Cancer","volume":"36","author":"Liao","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2020.12.025_bib0115","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1002\/cncr.25848","article-title":"Early findings on toxicity of proton beam therapy with concurrent chemotherapy for non-small cell lung cancer","volume":"117","author":"Sejpal","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2020.12.025_bib0120","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.1002\/cncr.26080","article-title":"Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III non-small cell lung cancer","volume":"117","author":"Chang","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2020.12.025_bib0125","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ijrobp.2010.06.024","article-title":"Proton beam therapy of Stage II and III non-small-cell lung cancer","volume":"81","author":"Nakayama","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.lungcan.2020.12.025_bib0130","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/JTO.0b013e31823c485f","article-title":"Results of proton beam therapy without concurrent chemotherapy for patients with unresectable stage III non-small cell lung cancer","volume":"7","author":"Oshiro","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2020.12.025_bib0135","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.2032","article-title":"Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study","volume":"3","author":"Chang","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.lungcan.2020.12.025_bib0140","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.radonc.2015.05.014","article-title":"Long-term outcomes after proton therapy, with concurrent chemotherapy, for stage II-III inoperable non-small cell lung cancer","volume":"115","author":"Nguyen","year":"2015","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.lungcan.2020.12.025_bib0145","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ijrobp.2015.11.004","article-title":"A phase 2 trial of concurrent chemotherapy and proton therapy for stage III non-small cell lung Cancer: results and reflections following early closure of a single-institution study","volume":"95","author":"Hoppe","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"July 3","key":"10.1016\/j.lungcan.2020.12.025_bib0150","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ijrobp.2020.03.015","article-title":"Hypofractionated proton therapy with concurrent chemotherapy for locally advanced non-small cell lung Cancer: a phase 1 trial from the university of Florida and proton collaborative group","volume":"107","author":"Hoppe","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.lungcan.2020.12.025_bib0155","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijrobp.2016.10.001","article-title":"National Cancer database analysis of proton versus photon radiation therapy in non-small cell lung Cancer","volume":"97","author":"Higgins","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.lungcan.2020.12.025_bib0160","doi-asserted-by":"crossref","DOI":"10.3109\/0284186X.2013.769063","article-title":"Dosimetric rationale and early experience at UFPTI of thoracic proton therapy and chemotherapy in limited-stage small cell lung cancer","volume":"52","author":"Colaco","year":"2013","journal-title":"Acta Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2020.12.025_bib0165","first-page":"20","article-title":"Comparison of intensity-modulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for small cell lung cancer","volume":"5","author":"Lu","year":"2016","journal-title":"Appl Radiat Oncol."},{"issue":"4244-4251","key":"10.1016\/j.lungcan.2020.12.025_bib0170","article-title":"Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer","volume":"123","author":"Rwigema","year":"2017","journal-title":"Cancer"},{"issue":"4837\u201345","key":"10.1016\/j.lungcan.2020.12.025_bib0175","article-title":"Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer","volume":"22","author":"Fried","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"249-58","key":"10.1016\/j.lungcan.2020.12.025_bib0180","article-title":"Using treatment interruptions to palliate the toxicity from concurrent chemoradiation for limited small cell lung cancer decreases survival and disease control","volume":"33","author":"Videtic","year":"2001","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2020.12.025_bib0185","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S1470-2045(17)30318-2","article-title":"Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial","volume":"18","author":"Faivre-Finn","year":"2017","journal-title":"Lancet Oncol."},{"issue":"7","key":"10.1016\/j.lungcan.2020.12.025_bib0190","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jtho.2019.03.030","volume":"14","author":"Gomez","year":"2019","journal-title":"J. Thorac. Oncol."},{"issue":"216\u201325","key":"10.1016\/j.lungcan.2020.12.025_bib0195","article-title":"Adjuvant intensity-modulated proton therapy in malignant pleural mesothelioma. A comparison with intensity-modulated radiotherapy and a spot size variation assessment","volume":"188","author":"Lorentini","year":"2012","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.lungcan.2020.12.025_bib0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.prro.2014.11.005","article-title":"Early experience with intensity modulated proton therapy for lung-intact mesothelioma: a case series","volume":"5","author":"Pan","year":"2015","journal-title":"Pract. Radiat. Oncol."},{"issue":"350\u20137","key":"10.1016\/j.lungcan.2020.12.025_bib0205","article-title":"Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma","volume":"69","author":"Rice","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.lungcan.2020.12.025_bib0210","article-title":"Prospective assessment of proton therapy for malignant pleural mesothelioma","author":"Li","year":"2015","journal-title":"International Association for the Study of Lung Cancer 16th World Conference on Lung Cancer"},{"issue":"3","key":"10.1016\/j.lungcan.2020.12.025_bib0215","doi-asserted-by":"crossref","first-page":"e664","DOI":"10.1016\/j.ijrobp.2018.07.1798","article-title":"Toxicities and clinical outcomes of whole pleural intensity-modulated proton therapy for lung-intact malignant pleural mesothelioma","volume":"102","author":"Molitoris","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"411\u2013418","key":"10.1016\/j.lungcan.2020.12.025_bib0220","article-title":"A novel prospective study assessing the combination of photodynamic therapy and proton radiation therapy: safety and outcomes when treating malignant pleural mesothelioma","volume":"95","author":"Rice","year":"2019","journal-title":"Photochem. Photobiol."},{"issue":"887-94","key":"10.1016\/j.lungcan.2020.12.025_bib0225","article-title":"Thymoma: benign appearance, malignant potential","volume":"11","author":"Riedel","year":"2006","journal-title":"Oncologist"},{"issue":"S260-5","key":"10.1016\/j.lungcan.2020.12.025_bib0230","article-title":"Epidemiology of thymoma and associated malignancies","volume":"5","author":"Engels","year":"2010","journal-title":"J. Thorac. Oncol."},{"issue":"362\u2013366","key":"10.1016\/j.lungcan.2020.12.025_bib0235","article-title":"Adjuvant proton beam therapy in the management of thymoma: a dosimetric comparison and acute toxicities","volume":"17","author":"Parikh","year":"2016","journal-title":"Clin. Lung Cancer"},{"issue":"120\u2013126","key":"10.1016\/j.lungcan.2020.12.025_bib0240","article-title":"An in silico planning study comparing doses and estimated risk of toxicity in 3D-CRT, IMRT and proton beam therapy of patients with thymic tumours","volume":"60","author":"Lidestahl","year":"2019","journal-title":"Phys. Med."},{"issue":"8","key":"10.1016\/j.lungcan.2020.12.025_bib0245","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1080\/0284186X.2017.1302097","article-title":"Risk of major cardiac events following adjuvant proton versus photon radiation therapy for patients with thymic malignancies","volume":"56","author":"Vogel","year":"2017","journal-title":"Acta Oncol. (Madr)"},{"issue":"504\u20139","key":"10.1016\/j.lungcan.2020.12.025_bib0250","article-title":"Prospective study of proton beam radiation therapy for adjuvant and definitive treatment of thymoma and thymic carcinoma: early response and toxicity assessment","volume":"118","author":"Vogel","year":"2016","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.lungcan.2020.12.025_bib0255","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1080\/0284186X.2019.1575981","article-title":"Proton therapy for thymic malignancies: multi-institutional patterns-of-care and early clinical outcomes from the proton collaborative group and the university of Florida prospective registries","volume":"58","author":"Mercado","year":"2019","journal-title":"Acta Oncol."},{"key":"10.1016\/j.lungcan.2020.12.025_bib0260","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ijrobp.2017.04.022","article-title":"Predicted rate of secondary malignancies following adjuvant proton versus photon radiation therapy for thymoma","volume":"99","author":"Vogel","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"13","key":"10.1016\/j.lungcan.2020.12.025_bib0265","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1200\/JCO.2016.71.5581","article-title":"New era I radiation oncology for lung Cancer: recognizing the importance of cardiac irradiation","volume":"35","author":"Simone","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2020.12.025_bib0270","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.ijrobp.2018.11.013","article-title":"Early changes in cardiovascular biomarkers with contemporary thoracic radiation therapy for breast Cancer, lung Cancer, and lymphoma","volume":"103","author":"Demissei","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"160\u20133","key":"10.1016\/j.lungcan.2020.12.025_bib0275","article-title":"Thoracic reirradiation for symptomatic relief after prior radiotherapeutic management for lung cancer","volume":"23","author":"Gressen","year":"2000","journal-title":"Am. J. Clin. Oncol."},{"issue":"390\u20136","key":"10.1016\/j.lungcan.2020.12.025_bib0280","article-title":"Reirradiation for locally recurrent lung cancer previously treated with radiation therapy","volume":"52","author":"Okamoto","year":"2002","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1345\u201350","key":"10.1016\/j.lungcan.2020.12.025_bib0285","article-title":"Three-dimensional conformal radiotherapy for locoregionally recurrent lung carcinoma after external beam irradiation: a prospective phase I-II clinical trial","volume":"57","author":"Wu","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"819\u201327","key":"10.1016\/j.lungcan.2020.12.025_bib0290","article-title":"Definitive reirradiation for locoregionally recurrent non-small cell lung cancer with proton beam therapy or intensity modulated radiation therapy: predictors of high-grade toxicity and survival outcomes","volume":"90","author":"McAvoy","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"38\u201344","key":"10.1016\/j.lungcan.2020.12.025_bib0295","article-title":"Feasibility of proton beam therapy for reirradiation of locoregionally recurrent non-small cell lung cancer","volume":"109","author":"McAvoy","year":"2013","journal-title":"Radiother. Oncol."},{"issue":"281\u2013292","key":"10.1016\/j.lungcan.2020.12.025_bib0300","article-title":"Multi-institutional prospective study of reirradiation with proton beam radiotherapy for locoregionally recurrent non-small cell lung Cancer","volume":"12","author":"Chao","year":"2017","journal-title":"J. Thorac. Oncol."},{"issue":"58\u201365","key":"10.1016\/j.lungcan.2020.12.025_bib0305","article-title":"Reirradiation of thoracic cancers with intensity modulated proton therapy","volume":"8","author":"Ho","year":"2018","journal-title":"Pract. Radiat. Oncol."},{"issue":"280\u2013288","key":"10.1016\/j.lungcan.2020.12.025_bib0310","article-title":"Clinical outcomes of patients with recurrent lung Cancer Reirradiated with proton therapy on the proton collaborative group and university of Florida proton therapy institute prospective registry studies","volume":"9","author":"Badiyan","year":"2019","journal-title":"Pract. Radiat. Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2020.12.025_bib0315","doi-asserted-by":"crossref","first-page":"56","DOI":"10.21037\/cco.2016.06.03","article-title":"Cost-comparativeness of proton versus photon therapy","volume":"5","author":"Verma","year":"2016","journal-title":"Chin. Clin. Oncol."},{"issue":"357\u201366","key":"10.1016\/j.lungcan.2020.12.025_bib0320","volume":"77","author":"Zhang","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"809\u201318","key":"10.1016\/j.lungcan.2020.12.025_bib0325","article-title":"Clinical implementation of intensity modulated proton therapy for thoracic malignancies","volume":"90","author":"Chang","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"4","key":"10.1016\/j.lungcan.2020.12.025_bib0330","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/0284186X.2017.1293287","article-title":"A study of the beam-specific interplay effect in proton pencil beam scanning delivery in lung cancer","volume":"56","author":"Kang","year":"2017","journal-title":"Acta Oncol. (Madr)"},{"issue":"November 3","key":"10.1016\/j.lungcan.2020.12.025_bib0335","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ijrobp.2016.06.2454","article-title":"Limited impact of setup and range uncertainties, breathing motion, and interplay effects in robustly optimized intensity modulated proton therapy for stage III non-small cell lung cancer","volume":"96","author":"Inoue","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"February","key":"10.1016\/j.lungcan.2020.12.025_bib0340","first-page":"35","article-title":"Relative biological effectiveness in proton beam therapy \u2013 current knowledge and future challenges","volume":"9","author":"Luhr","year":"2018","journal-title":"Clin Transl Radiat Oncol."},{"issue":"205\u201312","key":"10.1016\/j.lungcan.2020.12.025_bib0345","article-title":"Proton irradiation sensitizes radioresistant non-small cell lung Cancer cells by modulating epidermal growth factor receptor-mediated DNA repair","volume":"36","author":"Park","year":"2016","journal-title":"Anticancer Res."},{"issue":"1007\u201312","key":"10.1016\/j.lungcan.2020.12.025_bib0350","article-title":"Metastatic potential in MDA-MB-231 human breast cancer cells is inhibited by proton beam irradiation via the Akt\/nuclear factor-kappaB signaling pathway","volume":"10","author":"Lee","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"37\u201342","key":"10.1016\/j.lungcan.2020.12.025_bib0355","article-title":"Predictors of distant failure after stereotactic body radiation therapy for stages I to IIA non-small-Cell lung Cancer","volume":"20","author":"Miller","year":"2019","journal-title":"Clin. Lung Cancer"},{"issue":"120\u2013130","key":"10.1016\/j.lungcan.2020.12.025_bib0360","article-title":"Tumor cells surviving exposure to proton or photon radiation share a common immunogenic modulation signature, rendering them more sensitive to t cell-mediated killing","volume":"95","author":"Gameiro","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.lungcan.2020.12.025_bib0365","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1748-717X-9-183","article-title":"Particle beam radiation therapy using carbon ions and protons for oligometastatic lung tumors","volume":"9","author":"Sulaiman","year":"2014","journal-title":"Radiat. Oncol."},{"issue":"July 4","key":"10.1016\/j.lungcan.2020.12.025_bib0370","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ijrobp.2018.03.056","article-title":"Proton stereotactic radiosurgery for brain metastases: a single institution analysis of 370 patients","volume":"101","author":"Atkins","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.lungcan.2020.12.025_bib0375","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.critrevonc.2018.01.003","article-title":"A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors","volume":"123","author":"Venkatesulu","year":"2018","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"December 12","key":"10.1016\/j.lungcan.2020.12.025_bib0380","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/hed.23535","article-title":"The association between severe treatment-related lymphopenia and progression free survival in patients with newly diagnosed squamous cell head and neck cancer","volume":"36","author":"Campian","year":"2014","journal-title":"Head Neck"},{"issue":"March 3","key":"10.1016\/j.lungcan.2020.12.025_bib0385","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/07357907.2013.767342","article-title":"Treatment-related lymphopenia in patients with stage III non-small-cell lung cancer","volume":"31","author":"Campian","year":"2013","journal-title":"Cancer Invest."},{"key":"10.1016\/j.lungcan.2020.12.025_bib0390","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ijrobp.2014.04.025","article-title":"Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes","volume":"89","author":"Tang","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500220307522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500220307522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:50:25Z","timestamp":1759236625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500220307522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":78,"alternative-id":["S0169500220307522"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2020.12.025","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Where are we with proton beam therapy for thoracic malignancies? Current status and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2020.12.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}